Substantial evidence indicates that AMD has a strong genetic component, including the recent discoveries of polymorphisms in genes involved in the regulation of the immune-mediated complement pathway including complement factor H (CFH), complement factor B, complement component 2, and complement component 3 (C3) [2–7]. Here, C3 is linked to age-related macular degeneration.